NCT03242811

Brief Summary

It is important that asylum seekers should have as accurate age assessment as possible and that children's fundamental rights are met by choosing methods based on best available knowledge. The aim is to provide, on the basis of best available knowledge, suggestions for methods of medical age assessment of whether a person is over or under 18 years of age. The primary issue is to investigate whether five selected growth zones in knee joint, ankle and wrist individually or in combination can better determine the 18-year limit compared with previous research.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
958

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2017

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 16, 2017

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

July 23, 2017

Completed
16 days until next milestone

First Posted

Study publicly available on registry

August 8, 2017

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2018

Completed
Last Updated

June 6, 2018

Status Verified

June 1, 2018

Enrollment Period

11 months

First QC Date

July 23, 2017

Last Update Submit

June 5, 2018

Conditions

Keywords

Medical age assessment

Outcome Measures

Primary Outcomes (1)

  • Number of participants with correctly classified age (below or above 18 years) when 5 different growth zones in the knee, ankle and wrist are examined by MRI and analysed individually and in combination to determine the maturity.

    With 1.5 Tesla magnetic camera with dedicated cartilage sequence, selected growth zones will be investigated: knee joint, ankle joint including heel leg and wrist. The non-dominant body half will be investigated. In order to evaluate the growth zone with the highest precision, we have chosen T2-weighted gradient-recalled echo sequence, called mFFE / MERGE® / MEDIC® by various suppliers. The sequence is used in the clinical practice to assess various types of abnormalities in the cartilage. Two independent and blinded child radiologists shall examine MR images of 5 growth zones of each participant. All sections of each growth zone are to be examined and the cut is selected which shows the highest degree of closing / maturity for grading. Each growth zone will be examined and classified as being mature or non-mature.

    1 day

Study Arms (1)

Examination by MRI

EXPERIMENTAL

MRI scan of knee, ankle and wrist

Diagnostic Test: MRI scan of knee, ankle and wrist

Interventions

At the day of the intervention, the subject is informed about the study by a nurse and provides written informed consent. Girls must leave urine tests to rule out pregnancy. The questionnaire for the study is answered by the subject and weight and length are measured. The subject is asked to self-assess his/her puberty. After detailed information on how a magnetic camera examination is carried out, an examination of five selected growth zones (knee joint, ankle joint including heel leg and wrist) is performed using 1.5 Tesla magnetic camera with dedicated cartilage sequence.

Also known as: Self assessment of puberty by Tanner scale, Questionnaire on socioeconomics
Examination by MRI

Eligibility Criteria

Age14 Years - 21 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Healthy children / young adults without prior illness (such as asthma, growth hormone treatment, prolonged peroral cortisone treatment, cancer treatment, diabetes, rheumatic disease) that may have affected growth can be included in the study.

You may not qualify if:

  • Children or adolescents with ongoing drug treatment for chronic disease.
  • Contraindication against MRI examination
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Blekinge Institute of Technology

Karlskrona, 37179, Sweden

Location

Karolinska Institute

Stockholm, Sweden

Location

Study Officials

  • Sandra Diaz, MD, PhD

    Karolinska Institutet

    PRINCIPAL INVESTIGATOR
  • Johan Sanmartin Berglund, MD, PhD

    Blekinge Institute of Technology

    PRINCIPAL INVESTIGATOR
  • Carl-Erik Flodmark, MD, PhD

    Ministry of Health and Social Affairs, Sweden

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Unit Manager Karolinska Trial Alliance

Study Record Dates

First Submitted

July 23, 2017

First Posted

August 8, 2017

Study Start

June 16, 2017

Primary Completion

April 30, 2018

Study Completion

April 30, 2018

Last Updated

June 6, 2018

Record last verified: 2018-06

Data Sharing

IPD Sharing
Will not share

Locations